Form 4 for INMB Inmune Bio, Inc.
Accepted 2021-09-08 00:00:00 ET · period of report 2021-09-03 · accession 0001415889-21-004281 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-08 | 2021-09-03 | INMB | Xencor Inc | 10% | M - OptEx | $7.80 | +108.0K | 1.89M | +6% | +$842.4K |
| D | 2021-09-08 | 2021-09-03 | INMB | Xencor Inc | 10% | M - OptEx | $0.00 | -108.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-03 | M | A | 108,000 | $7.80 | 1,885,533 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2021-09-03 | M | D | 108,000 | $0.00 | 0 | D | $7.80 · — to 2021-09-08 | 108,000 Common Stock | (F1) The shares underlying this option vested in 36 equal monthly installments beginning on April 3, 2018. |